The Merck Company Foundation, the philanthropic arm of US drug major Merck & Co, has announced the launch of The Alliance to Reduce Disparities in Diabetes, a new initiative designed to improve health care delivery among those populations most at risk - African-Americans, Hispanics and Native American adults. The US Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and the Office of Minority Health joined the Foundation in support of the Alliance's goal to mobilize community-based partners and enhance the delivery of proven, collaborative approaches that can close gaps in diabetes care.
Research shows insufficient health resources, poor disease management, inadequate patient education and support, as well as individual perceptions about how difficult it is to manage and prevent diabetes all contribute to health care disparities. These problems are more acute in low-income, disadvantaged communities. The initiative will engage a range of health care stakeholders, including patients, providers and health system leaders, to assist at the grassroots level in five US communities and mobilize allies at the national and state levels.
Becoming a mobilizing force
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze